about
Future Perspectives of ERAS: A Narrative Review on the New Applications of an Established ApproachMechanisms of low back pain: a guide for diagnosis and therapyFrom micro- to nanostructured implantable device for local anesthetic deliveryInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsCombining pain therapy with lifestyle: the role of personalized nutrition and nutritional supplements according to the SIMPAR Feed Your Destiny approachThe 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its UseDoes a research group increase impact on the scientific community or general public discussion? Alternative metric-based evaluationValidation of standard operating procedures in a multicenter retrospective study to identify -omics biomarkers for chronic low back pain.Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patientsReduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case seriesCost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.Pain assessment in animal models: do we need further studies?Continuous wound infusion of local anesthetic and steroid after major abdominal surgery: study protocol for a randomized controlled trial.Opioids and chronic pain. Data from the "other side of the pond".Continuous peripheral nerve blocks: state of the art.Effect of Preoperative Inflammatory Status and Comorbidities on Pain Resolution and Persistent Postsurgical Pain after Inguinal Hernia Repair.The Association Between Low Back Pain and Composition of IgG GlycomeChanges in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.'Omics' biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study.How and why to screen for CYP2D6 interindividual variability in patients under pharmacological treatments.Acute and chronic pain: where we are and where we have to go.Morphine metabolism, transport and brain disposition.A year in review in Minerva Anestesiologica 2012.Chronic pain management in pregnancy and lactation.A year in review in Minerva Anestesiologica 2013.Pharmacokinetic considerations for therapies used to treat interstitial cystitis.OPRM1 receptor as new biomarker to help the prediction of post mastectomy pain and recurrence in breast cancer.Effects of anaesthesia and analgesia on long-term outcome after total knee replacement: A prospective, observational, multicentre study.Opioids for chronic non-cancer pain: a critical view from the other side of the pond.The prevention of analgesic opioids abuse: expert opinion.A year in review in Minerva Anestesiologica 2015.Past, Present, and Future of Informed Consent in Pain and Genomics Research: Challenges Facing Global Medical Community.Human Genetic Variability Contributes to Postoperative Morphine Consumption.Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.A year in review in Minerva Anestesiologica 2016.Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.Using omics in chronic pain conditions to delineate mechanisms and provide new therapeutic strategies.Italian Registry of Complications associated with Regional Anesthesia (RICALOR). An incidence analysis from a prospective clinical survey.5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain.Peritoneal Nebulization of Ropivacaine during Laparoscopic Cholecystectomy: Dose Finding and Pharmacokinetic Study.
P50
Q26738360-84CE1846-FF8D-4F23-8286-E667B18B1DBEQ26740642-5ED27800-D043-4DF4-BFFA-1460C3AE3247Q26746221-06AFF2AC-1F1D-4D25-A83C-24EB94C9F2ACQ27009534-03F07AA1-A148-47D2-85CF-4DE7A7415895Q28068212-7258C4C2-082B-4217-BE3A-823C255A0FC1Q28069535-28B1D3FD-6B61-4158-94A7-4B4CA52D0291Q28601080-ACC8BE0A-CAEA-4E10-8713-ABEEBF5286A6Q33620767-3545076B-CCB1-4BAD-829A-D9C86D2C3FCAQ33739885-E866B425-9DF4-44A6-85B3-A268D8F7E78AQ33824504-01D34D4B-0005-4A1D-B25D-0131A78A31B4Q33842155-FC295FD5-4A9D-4C77-ADC3-F39D6AAEA40AQ35173022-22DA7641-5E6D-455D-9CCF-EAEC4FE2161EQ35954392-37734BC3-94FC-441F-A347-77393B545B6DQ36137830-94FEE83B-A724-4335-94B3-FA6CC05BE59BQ36420363-7AC1ADFA-DFE3-4D35-B0ED-C5350E603167Q36718959-DF3EDC7C-14FE-45D6-8896-E9E8D8A9A49DQ36941415-61C5ECA3-E619-42F3-ADEA-BD3988ED8325Q37159904-E004A8FE-3959-4046-B3C7-F7DD6D4F911FQ37356129-9F743C6A-9829-47A9-BEDE-3516BE19B477Q37822389-A61324F7-35DC-4405-9A27-44825516D88AQ37957728-559955B8-706D-4391-A890-E4D2514ADB3EQ37970914-48D9D752-D98E-49FB-AA17-01BD553919C2Q38095694-257A8744-9662-4E7A-8B19-144E1ACA2A6FQ38121819-8476E4F5-E337-4946-AC34-7EAC08D8588CQ38185523-7934DD68-F779-4ECD-B09B-7746DA50A13FQ38195318-9C37361B-C8FC-4F73-B2EE-406470D894C5Q38258575-F413E31D-1A61-4F6F-A1C2-ED522C08E877Q38372899-893D6D70-41A4-4A42-BDC4-5D9CEB2D8477Q38546934-E36C29F4-5AE4-4A67-A175-7CADAA528C3FQ38642624-F0FA2F0A-2FAD-439F-994E-9A26F25BEE29Q38715483-6240EBEE-C0BF-4D76-B895-216F170B8088Q38827717-4067450F-1A5C-4F5D-B47A-0C02E4793DA1Q38904856-2032C48A-75D9-45E4-B7F9-1AB8A718FBAFQ38952263-46B7C912-5389-4787-B409-728CFF9CAB17Q39132151-0F3CAAC4-09C4-444B-B0C4-FBEB0D174455Q39210844-BCE1BFC4-36EE-48F6-A7C3-F504D40A8D4CQ40856266-28CBD016-34E0-4C42-9378-2B4DF4C0AE7EQ40903989-B94FC9F1-2D93-4AC7-9AE2-585EBCA97E80Q41933385-8F2F9DC9-89A9-45B8-BA26-09CEE19C92E2Q42318230-AA054DD2-9B06-4F21-A683-3A63775B35DA
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Massimo Allegri
@ast
Massimo Allegri
@en
Massimo Allegri
@es
Massimo Allegri
@nl
Massimo Allegri
@sl
type
label
Massimo Allegri
@ast
Massimo Allegri
@en
Massimo Allegri
@es
Massimo Allegri
@nl
Massimo Allegri
@sl
prefLabel
Massimo Allegri
@ast
Massimo Allegri
@en
Massimo Allegri
@es
Massimo Allegri
@nl
Massimo Allegri
@sl
P214
P244
P1053
K-2946-2015
P106
P1153
6602160858
P1960
Z7WiuFYAAAAJ
P21
P214
P244
no2009108069
P31
P3829
P496
0000-0002-8201-980X
P734
P735
P7859
lccn-no2009108069